Market Size and Innovation: Effects of Medicare Part D on Pharmaceutical Research and Development

Journal of Public Economics - Netherlands
doi 10.1016/j.jpubeco.2012.10.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Effect of Medicare Part D on Pharmaceutical Prices and Utilization

American Economic Review
EconomicsEconometrics
2010English

Gabepentinoids and Benzodiazepines in Medicare Part D

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2018English

Innovation, Firm Size and Market Structure

OECD Economics Department Working Papers
1996English

The Effect of Depression and Cognitive Impairment on Enrollment in Medicare Part D

Journal of the American Geriatrics Society
GerontologyGeriatrics
2009English

Medicare Part D Payments for Topical Steroids

JAMA Dermatology
DermatologyMedicine
2017English

Changes to Medicare Part D: Who Benefits?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2010English

Government Payments and Insurer Benefit Design in Medicare Part D

SSRN Electronic Journal
2014English

Medicare Part D—A Roundtable Discussion of Current Issues and Trends

Journal of Managed Care Pharmacy
2009English

Medicare Part D Payments for Neurologist-Prescribed Drugs

Neurology
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy